Page last updated: 2024-10-31

clorgyline and Pulmonary Arterial Remodeling

clorgyline has been researched along with Pulmonary Arterial Remodeling in 1 studies

Clorgyline: An antidepressive agent and monoamine oxidase inhibitor related to PARGYLINE.
clorgyline : An aromatic ether that is the 2,4-dichlorophenyl ether of 3-aminopropan-1-ol in which the nitrogen is substituted by a methyl group and a prop-1-yn-3-yl group. A monoamine oxidase inhibitor, it was formerly used as an antidepressant.

Research Excerpts

ExcerptRelevanceReference
"Clorgyline treatment reduced RV afterload and pulmonary vascular remodeling in SuHx rats through reduced pulmonary vascular proliferation and oxidative stress."1.62Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension. ( Andersen, A; Andersen, S; Axelsen, JB; Bogaard, HJ; da Silva Goncalves Bos, D; de Man, FS; Gomez-Puerto, MC; Goumans, MJ; Kurakula, K; Pan, X; Peters, EL; Schalij, I; Schiepers, REJ; Sun, XQ; Szulcek, R; van der Laarse, WJ; Vonk Noordegraaf, A, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Sun, XQ1
Peters, EL1
Schalij, I1
Axelsen, JB1
Andersen, S1
Kurakula, K1
Gomez-Puerto, MC1
Szulcek, R1
Pan, X1
da Silva Goncalves Bos, D1
Schiepers, REJ1
Andersen, A1
Goumans, MJ1
Vonk Noordegraaf, A1
van der Laarse, WJ1
de Man, FS1
Bogaard, HJ1

Other Studies

1 other study available for clorgyline and Pulmonary Arterial Remodeling

ArticleYear
Increased MAO-A Activity Promotes Progression of Pulmonary Arterial Hypertension.
    American journal of respiratory cell and molecular biology, 2021, Volume: 64, Issue:3

    Topics: Animals; Clorgyline; Disease Models, Animal; Disease Progression; Heart Ventricles; Humans; Hypertro

2021